<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Effect of octreotide on serum IGF-1</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Effect of octreotide on serum IGF-1</h1>
<div class="graphic"><div class="figure"><div class="ttl">Effect of octreotide on serum IGF-1</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">In this study of previously untreated acromegalic patients, 18 with macroadenomas and 6 with microadenomas, short-acting octreotide was administered for 24 weeks and then long-acting octreotide to 15 of the patients for another 24 weeks. Open circles represent the pre-treatment IGF-1 concentration, bull's eye marks the values at 24 weeks, and the closed circles the values at 48 weeks. N indicates normal age-related IGF-1 concentration at latest assessment.</div><div class="graphic_footnotes">IGF-1: insulin-like growth factor-1.</div><div class="graphic_reference">Data from: Bevan JS, Atkin SL, Atkinson AB, et al. Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size. J Clin Endocrinol Metab 2002; 87:4554.</div><div id="graphicVersion">Graphic 62473 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
